Advanced Biomed Inc. is a biotech company that develops microfluidic technology platforms for oncology detection and cellular analysis, primarily focused on early cancer screening and diagnosis through the detection of circulating tumor cells in blood samples. The company offers an integrated suite of devices and consumables—including automated sample preparation systems, rare cell enrichment devices, cell analyzers with immunofluorescence staining, single-cell capture systems, and 3D cell culture incubators—along with companion immunostaining kits for identifying different cell phenotypes. Advanced Biomed generates revenue through direct sales of its diagnostic devices and consumables to hospitals and diagnostic laboratories, with expansion plans to enter North American and European markets through product registration and localized distribution partnerships.